SENESCO TECHNOLOGIES INC | 0,146 Euro | -0,002 -1,35 % | |
| WKN: 633433 ISIN: US8172084084 Ticker-Symbol: ST4 | Frankfurt | 10.02.12 | 15:38 Uhr |
Branche BiotechnologieAktienmarkt Sonstige |
|
| Zeit | Aktuelle Nachrichten | Leser | Medien | |
|---|---|---|---|---|
| 09.01. | Senesco Announces $2.0 Million Equity Financing | 22 | Business Wire | |
| Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE AMEX: SNT)
announced today that it has entered into a securities purchase
agreement to raise approximately... Mehr lesen zu: Senesco Announces $2.0 Million Equity Financing | ||||
| 05.01. | Senesco and Rahan Meristem (1998) LTD Enter Into New Agreement | 32 | Business Wire | |
| Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE AMEX: SNT)
announced today that it has re-structured its research and development
agreement with Rahan Meristem... Mehr lesen zu: Senesco and Rahan Meristem (1998) LTD Enter Into New Agreement | ||||
| 27.12. | NYSE Amex Accepts Senesco Technologies' Plan of Compliance | 25 | Business Wire | |
| Senesco Technologies, Inc. (the "Company" or "Senesco") (NYSE
Amex: SNT)
announced today that on December 22, 2011, it received
notice
from the NYSE Amex... Mehr lesen zu: NYSE Amex Accepts Senesco Technologies' Plan of Compliance | ||||
| 06.12. | Senesco to Present at the 53rd Annual Meeting of the American Society of Hematology on SNS01-T | 11 | Business Wire | |
| Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE AMEX: SNT)
announced today that it will deliver a poster presentation at the 53rd
Annual Meeting of ASH,... Mehr lesen zu: Senesco to Present at the 53rd Annual Meeting of the American Society of Hematology on SNS01-T | ||||
| 05.12. | Senesco Technologies, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com | 15 | PR Newswire | |
| NEW YORK, Dec. 5, 2011 /PRNewswire/ --Senesco Technologies, Inc. (NYSE AMEX: SNT) announced that their December 1st RetailInvestorConferences.com presentation is now available... Mehr lesen zu: Senesco Technologies, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com | ||||
| 01.12. | Senesco Receives Milestone Payment from Bayer CropScience | 50 | Business Wire | |
| Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE AMEX: SNT)
announced today that Bayer CropScience has made an undisclosed R&D
milestone payment related to... Mehr lesen zu: Senesco Receives Milestone Payment from Bayer CropScience | ||||
| 29.11. | Senesco Technologies, Inc. to Webcast, Live, at RetailInvestorConferences.com on December 1st | 14 | PR Newswire | |
| NEW YORK, Nov. 29, 2011 /PRNewswire/ --Senesco Technologies, Inc. (NYSE AMEX: SNT) announced that that Leslie J. Browne, Ph.D., President and CEO, will present at RetailInvestorConferences.com.
DATE:... Mehr lesen zu: Senesco Technologies, Inc. to Webcast, Live, at RetailInvestorConferences.com on December 1st | ||||
| 22.11. | Senesco to Present at NYSSA's 2011 Biotech / Specialty Pharma Conference | 20 | Business Wire | |
| Update on Recent Non-Clinical Efficacy Findings with SNS01-T
Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE AMEX: SNT)
announced that... Mehr lesen zu: Senesco to Present at NYSSA's 2011 Biotech / Specialty Pharma Conference | ||||
| 14.11. | SENESCO TECHNOLOGIES INC - 10-Q, Quarterly Report | - | SEC Filings | |
| 03.11. | Senesco Initiates Dosing in Phase 1b/2a Clinical Study of SNS01-T | 20 | Business Wire | |
| First in Human Study of eIF5A Modulation in Treatment of Disease
Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE Amex: SNT)
today announced... Mehr lesen zu: Senesco Initiates Dosing in Phase 1b/2a Clinical Study of SNS01-T | ||||
| 26.10. | Senesco Technologies Provides Corporate Update | 29 | Business Wire | |
| Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE AMEX: SNT)
provided an update on Company activities.
Clinical Trial Status Update
... Mehr lesen zu: Senesco Technologies Provides Corporate Update | ||||
| 26.10. | Senesco Technologies Receives Notice of Non-Compliance from NYSE Amex | 34 | Business Wire | |
| Senesco Technologies, Inc. (the "Company") (NYSE Amex: SNT) has
received a notice from the NYSE Amex LLC (the "NYSE Amex") providing
notification that the Company does... Mehr lesen zu: Senesco Technologies Receives Notice of Non-Compliance from NYSE Amex | ||||
| 24.10. | SENESCO TECHNOLOGIES INC - 10-K/A, Annual Report | - | SEC Filings | |
| 20.10. | Senesco Technologies to Present at BIO Investor Forum Conference | 28 | Business Wire | |
| Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE AMEX: SNT)
announced that the Company will be presenting at the BIO Investor Forum
conference on Tuesday... Mehr lesen zu: Senesco Technologies to Present at BIO Investor Forum Conference | ||||
| 29.09. | Senesco Technologies Reports Fiscal Year 2011 Financial Results | 14 | Business Wire | |
| Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE Amex: SNT)
today announced financial results for the 12 months ended June 30, 2011
("Fiscal 2011").
... Mehr lesen zu: Senesco Technologies Reports Fiscal Year 2011 Financial Results | ||||
| 06.09. | Senesco to Present at 13th Annual Rodman & Renshaw Healthcare Conference | 20 | Business Wire | |
| Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE AMEX: SNT)
announced that the Company will be presenting at the 13th
Annual Rodman & Renshaw Healthcare Conference... Mehr lesen zu: Senesco to Present at 13th Annual Rodman & Renshaw Healthcare Conference | ||||
| 24.08. | Senesco Finalizes Agreement with Mayo Clinic to Study SNS01-T in Multiple Myeloma | 23 | Business Wire | |
| Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE Amex: SNT)
today announced that it has finalized a clinical trial agreement with
Mayo Clinic in Rochester... Mehr lesen zu: Senesco Finalizes Agreement with Mayo Clinic to Study SNS01-T in Multiple Myeloma | ||||
Startseite • Nachrichten • Aktienkurse • Xetra-Orderbuch • Watchlist
Ad hoc-Mitteilungen • Chartanalysen • Nachrichten Börsen • Aktien-Empfehlungen
Branchen • Medien • Nachrichten-Archiv
Impressum | AGB | Disclaimer • Presse • Mediadaten
RSS-News von FinanzNachrichten.de kostenlos für Ihren Browser und Ihre Homepage
